Betta Pharmaceuticals (300558.SZ) issued a notice stating that the company has reviewed and approved the proposal to grant restricted stocks to incentive recipients for 2023...
According to the Zhithong Finance APP, Betta Pharmaceuticals (300558.SZ) announced that the company has reviewed and approved the proposal regarding the granting of the reserved part of the 2023 restricted stock incentive plan to incentive recipients, determining December 4, 2024, as the reserved granting date, with a granting price of 41 yuan per share to grant 1.6898 million restricted stocks to 171 eligible incentive recipients.
